I-Oxin Pharma Private Limited
About I-Oxin Pharma Private Limited
Data last updated:
I-Oxin Pharma Private Limited is a private limited company based in Bahyander East, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015PTC262595. Its GSTIN is 27AADCI7717E1ZL (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam Devi and Praveen Kumar Rajendra Prasad Tripathi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Shop No.2 A – Wing Bldg – A Ranuja Ramdev Park New Golden Nest Road Nr.Sai Ram Tower, Bahyander East, Maharashtra, India – 401105.
As per the financials filed for FY 2021, the company reported a revenue of ₹11.64 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net profit of ₹8,762 (net margin 0.8%) and EBITDA of ₹2.21 Lakh (EBITDA margin 19%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.2 A – Wing Bldg – A Ranuja Ramdev Park New Golden Nest Road Nr.Sai Ram Tower, Bahyander East, Maharashtra, India – 401105
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of I-Oxin Pharma Private Limited
The main business activity of I-Oxin Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of I-Oxin Pharma Private Limited
I-Oxin Pharma Private Limited is audited by RISHI SEKHRI AND ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RISHI SEKHRI AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of I-Oxin Pharma Private Limited
I-Oxin Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Devi Also directs: PVMT Pharma Private Limited | Director | 14 Mar 2022 | 4 Years 6 Months | Current |
| Praveen Kumar Rajendra Prasad Tripathi Also directs: PVMT Pharma Private Limited | Director | 10 Mar 2015 | 11 Years 6 Months | Current |
Financials of I-Oxin Pharma Private Limited FY 2021 filings available
I-Oxin Pharma Private Limited reported revenue of ₹11.64 Lakh (down 52% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of I-Oxin Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 52% fall in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of I-Oxin Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹11.64 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.21 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8,762 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of I-Oxin Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of I-Oxin Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of I-Oxin Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of I-Oxin Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jan 2019 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at I-Oxin Pharma Private Limited
Employment history and EPFO contributions of people linked to I-Oxin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of I-Oxin Pharma Private Limited
I-Oxin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCI7717E1ZL | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for I-Oxin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by I-Oxin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of I-Oxin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of I-Oxin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on I-Oxin Pharma Private Limited
Frequently Asked Questions about I-Oxin Pharma Private Limited
I-Oxin Pharma is an active private limited company based in Bahyander East, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 March 2015 (11+ years old) and is registered under CIN U74120MH2015PTC262595.
I-Oxin Pharma reported revenue of ₹11.64 Lakh for FY 2021 (down 52% YoY).
I-Oxin Pharma has 2 current directors:
- Poonam Devi - Director
- Praveen Kumar Rajendra Prasad Tripathi - Director
I-Oxin Pharma reported a net profit of ₹8,762 (net margin 0.8%) and EBITDA of ₹2.21 Lakh (EBITDA margin 19%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of I-Oxin Pharma is -22% over three years and -2% over five years. In the latest year (FY 2021) revenue fell 52%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of I-Oxin Pharma is 27AADCI7717E1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of I-Oxin Pharma is U74120MH2015PTC262595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Oxin Pharma was incorporated on 10 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of I-Oxin Pharma is at Shop No.2 A – Wing Bldg – A Ranuja Ramdev Park New Golden Nest Road Nr.Sai Ram Tower, Bahyander East, Maharashtra, India – 401105.